Skip to main content
. 2024 Oct 26;16(10):e72420. doi: 10.7759/cureus.72420

Table 5. Assessment of changes in inflammatory biomarker levels between groups.

Values represent the mean score ± SD. The data was analyzed using the independent Student's t-test for between-group comparisons and the dependent t-test for within-group comparisons. Significant at p< 0.05.

* - denotes within group p values <0.001

Visits EnMax Placebo Marketed reference
C-reactive protein levels (mg/dL)
Visit 1 10.84± 2.95 10.60±3.26 11.02±3.79
Visit 4 5.28±2.08 (51.24%) 8.18±2.60* (22.82 %) 7.14±2.09 (35.23 %)
P-value <0.001 <0.001 <0.001
Visit 1 22.77± 5.41 21.58±5.29 23.38 ±5.88
Visit 4 9.15±4.79 (59.80 %) 15.19±6.32* (29.59%) 12.54±5.06 (46.38 %)
P-value <0.001 <0.001 <0.001